EVT-401 is a small molecule oral P2X7 receptor antagonist investigated for the treatment of inflammatory conditions, including rheumatoid arthritis. This category provides essential reference standards… Read more
EVT-401 is a small molecule oral P2X7 receptor antagonist investigated for the treatment of inflammatory conditions, including rheumatoid arthritis. This category provides essential reference standards for the parent compound, its key metabolites, such as M3 and M4, and their stable isotope labelled analogues. Pharmaceutical laboratories utilize these high-quality materials for precise analytical testing and rigorous quality control during drug development. Metabolite standards and stable isotope labelled compounds, such as the d3 and d5 variants listed here, are critical for accurate quantification and impurity profiling in complex biological matrices. By incorporating these compounds into pharmacokinetic studies and method validation protocols, researchers can ensure the reproducibility and reliability of their analytical data throughout the lifecycle of the drug candidate.